PL2663297T3 - Sposoby i kompozycje do ochrony komórek i tkanek przed promieniowaniem w trakcie tomografii komputerowej - Google Patents

Sposoby i kompozycje do ochrony komórek i tkanek przed promieniowaniem w trakcie tomografii komputerowej

Info

Publication number
PL2663297T3
PL2663297T3 PL11771290T PL11771290T PL2663297T3 PL 2663297 T3 PL2663297 T3 PL 2663297T3 PL 11771290 T PL11771290 T PL 11771290T PL 11771290 T PL11771290 T PL 11771290T PL 2663297 T3 PL2663297 T3 PL 2663297T3
Authority
PL
Poland
Prior art keywords
tissues
compositions
cells
protection
methods
Prior art date
Application number
PL11771290T
Other languages
English (en)
Inventor
David J. Grdina
Original Assignee
The University Of Chicago
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The University Of Chicago filed Critical The University Of Chicago
Publication of PL2663297T3 publication Critical patent/PL2663297T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/02—Arrangements for diagnosis sequentially in different planes; Stereoscopic radiation diagnosis
    • A61B6/03—Computed tomography [CT]
    • A61B6/032—Transmission computed tomography [CT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/50—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications
    • A61B6/508—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications for non-human patients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/132—Amines having two or more amino groups, e.g. spermidine, putrescine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physics & Mathematics (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Surgery (AREA)
  • Optics & Photonics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dentistry (AREA)
  • Inorganic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Theoretical Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL11771290T 2010-09-16 2011-09-16 Sposoby i kompozycje do ochrony komórek i tkanek przed promieniowaniem w trakcie tomografii komputerowej PL2663297T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38359210P 2010-09-16 2010-09-16
EP11771290.1A EP2663297B1 (en) 2010-09-16 2011-09-16 Methods and compositions for protection of cells and tissues from computed tomography radiation
PCT/US2011/051946 WO2012037466A2 (en) 2010-09-16 2011-09-16 Methods and compositions for protection cells and tissues from computed tomography radiation

Publications (1)

Publication Number Publication Date
PL2663297T3 true PL2663297T3 (pl) 2020-07-13

Family

ID=44860501

Family Applications (2)

Application Number Title Priority Date Filing Date
PL19194979.1T PL3632419T3 (pl) 2010-09-16 2011-09-16 Sposoby i kompozycje do ochrony komórek i tkanek przed promieniowaniem w trakcie tomografii komputerowej
PL11771290T PL2663297T3 (pl) 2010-09-16 2011-09-16 Sposoby i kompozycje do ochrony komórek i tkanek przed promieniowaniem w trakcie tomografii komputerowej

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL19194979.1T PL3632419T3 (pl) 2010-09-16 2011-09-16 Sposoby i kompozycje do ochrony komórek i tkanek przed promieniowaniem w trakcie tomografii komputerowej

Country Status (7)

Country Link
US (3) US9877976B2 (pl)
EP (2) EP2663297B1 (pl)
ES (2) ES2935508T3 (pl)
HU (2) HUE061796T2 (pl)
PL (2) PL3632419T3 (pl)
PT (1) PT3632419T (pl)
WO (1) WO2012037466A2 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3632419T3 (pl) * 2010-09-16 2023-07-03 The University Of Chicago Sposoby i kompozycje do ochrony komórek i tkanek przed promieniowaniem w trakcie tomografii komputerowej
AU2018205040A1 (en) * 2016-12-31 2019-07-11 Radiation Barrier Llc Reducing damage from radiation therapy and increasing cancer kill rates by interweaving of low and high dose sessions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5869338A (en) * 1992-03-13 1999-02-09 Arch Development Corporation Method for protection against genotoxic mutagenesis
US5567686A (en) 1992-03-13 1996-10-22 Arch Development Corporation Method for protection against genotoxic mutagenesis
US5488042A (en) * 1992-03-13 1996-01-30 Arch Development Corporation Method for protection against genotoxic mutagenesis
US20030114379A1 (en) * 1994-03-08 2003-06-19 Human Genome Sciences, Inc. Methods of treating or preventing cell, tissue, and organ damage using human myeloid progenitor inhibitory factor-1 (MPIF-1)
US6984619B1 (en) * 1999-03-19 2006-01-10 Arch Development Corporation Method for protection against tumor metastasis formation
PL3632419T3 (pl) * 2010-09-16 2023-07-03 The University Of Chicago Sposoby i kompozycje do ochrony komórek i tkanek przed promieniowaniem w trakcie tomografii komputerowej

Also Published As

Publication number Publication date
EP2663297B1 (en) 2019-10-23
US10987366B2 (en) 2021-04-27
EP2663297A2 (en) 2013-11-20
EP3632419B1 (en) 2022-12-28
HUE048554T2 (hu) 2020-07-28
US20210244751A1 (en) 2021-08-12
WO2012037466A3 (en) 2012-05-10
US20180193363A1 (en) 2018-07-12
PT3632419T (pt) 2023-01-31
WO2012037466A8 (en) 2013-02-14
US9877976B2 (en) 2018-01-30
US20130251634A1 (en) 2013-09-26
ES2935508T3 (es) 2023-03-07
HUE061796T2 (hu) 2023-08-28
PL3632419T3 (pl) 2023-07-03
WO2012037466A2 (en) 2012-03-22
ES2759499T3 (es) 2020-05-11
EP3632419A1 (en) 2020-04-08

Similar Documents

Publication Publication Date Title
DK2608777T3 (en) Compositions and Methods for Cardiac Therapy
IL245535A0 (en) A method for introducing cells from solid tissues
HK1165332A1 (en) Compositions and methods for preventing cardiac arrhythmia
IL225471A0 (en) Preparations and methods for the prevention and treatment of cancer
EP2611413A4 (en) SKIN COMPOSITIONS AND THEIR APPLICATIONS
EP2603202A4 (en) COMPOSITIONS AND METHOD FOR THE TREATMENT OF TAUOPATHIES
HK1178074A1 (en) Compositions and methods for the diagnosis and treatment of tumor
ZA201300567B (en) Methods and compositions for liver cancer therapy
IL251083B (en) Compounds and preparations for the treatment of cancer
EP2537530A4 (en) RADIOTHERAPY AGENT
EP2558085A4 (en) COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF CANCER
IL225793A0 (en) Methods and preparations for curing insulin-related medical conditions
EP2598150A4 (en) COMPOSITIONS FOR PROLIFERATING CELLS AND ASSOCIATED METHODS
IL217535A0 (en) Compositions and methods of use for post-radiation protection
HK1184362A1 (en) Methods and compositions for inhibition of treg cells treg
ZA201302952B (en) Fungicidal compositions and methods of use
PL2663297T3 (pl) Sposoby i kompozycje do ochrony komórek i tkanek przed promieniowaniem w trakcie tomografii komputerowej
EP2547368A4 (en) METHOD AND COMPOSITIONS FOR CANCER TREATMENT
EP2637501A4 (en) FUNGICIDES AND METHODS OF USE THEREOF
AU2010900496A0 (en) Methods and compositions for inhibiting growth of cancerous cells